Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Janux Therapeutics, Inc. | 32,270 | reported | 11 May 2026 | tx 6+107,035−3,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 May 2026 | SALE | Janux Therapeutics, Inc. | 2,038 | 14.17 USD | |
| 02 Jan 2026 | GRANT_AWARD | Janux Therapeutics, Inc. | 18,935 | 0.00 USD | |
| 02 Jan 2026 | SALE | Janux Therapeutics, Inc. | 1,462 | 13.73 USD | |
| 02 Jan 2026 | GRANT_AWARD | Janux Therapeutics, Inc. | 42,600 | 0.00 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | Janux Therapeutics, Inc. | 14,000 | 0.00 USD | |
| 02 Jan 2025 | GRANT_AWARD | Janux Therapeutics, Inc. | 31,500 | 0.00 USD | deriv |